Classification of Anticancer Drugs Based on Therapeutic Targets
作者： Enrique Espinosa , César Gómez Raposo
DOI: 10.1007/978-1-4419-0507-9_1
关键词:
摘要: The arrival of a great number new antineoplastic agents has made it necessary to reclassify all them. Virtually any mechanism that can provide tumour cells with proliferative advantages over normal is being investigated in the search for active drugs. Growth factors and their receptors, intracellular metabolic pathways, pro-angiogenic molecules many more have become potential targets.
springer.com
sci-hub.st 参考文章(104)
Sonia A. Perez, Michael Papamichail, Cancer immunotherapy: perspectives and prospects. Advances in Experimental Medicine and Biology. ,vol. 622, pp. 235- 253 ,(2008) , 10.1007/978-0-387-68969-2_19
B. Brockstein, B. Samuels, R. Humerickhouse, R. Arietta, P. Fishkin, J. Wade, J. Sosman, E.E. Vokes, Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer. Investigational New Drugs. ,vol. 19, pp. 249- 254 ,(2001) , 10.1023/A:1010628903248
Enrique A. Mesri, Celina G. Kleer, Sofia D. Merajver, Diane M. Robins, Quintin Pan, Carlos Bias, Kristen M. Bottema, Jennifer Irani, George J. Brewer, Robert D. Dick, Kenneth L. Van Golen, Magda De Carvalho, Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Research. ,vol. 62, pp. 4854- 4859 ,(2002)
Tzy-Jyun Yao, L. Williams, P. B. Chapman, M. Mccaffery, P. O. Livingston, A. N. Houghton, Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant. Clinical Cancer Research. ,vol. 2, pp. 679- 686 ,(1996)
S. Delaloge, A. Yovine, A. Taamma, M. Riofrio, E. Brain, E. Raymond, P. Cottu, F. Goldwasser, J. Jimeno, J. L. Misset, M. Marty, E. Cvitkovic, Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients—Preliminary Evidence of Activity Journal of Clinical Oncology. ,vol. 19, pp. 1248- 1255 ,(2001) , 10.1200/JCO.2001.19.5.1248
Julie M Vose, Richard L Wahl, Mansoor Saleh, Ama Z Rohatiner, Susan J Knox, John A Radford, Andrew D Zelenetz, George F Tidmarsh, Robert J Stagg, Mark S Kaminski, None, Multicenter phase II study of iodine-131 tositumomab for chemotherapy- relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas Journal of Clinical Oncology. ,vol. 18, pp. 1316- 1323 ,(2000) , 10.1200/JCO.2000.18.6.1316
Andrew M. Scott, Fook-Thean Lee, Wendie Hopkins, Jonathan S. Cebon, Jennifer M. Wheatley, Zhanqi Liu, Fiona E. Smyth, Carmel Murone, Susan Sturrock, Duncan MacGregor, Nobuo Hanai, Kengo Inoue, Motoo Yamasaki, Martin W. Brechbiel, Ian D. Davis, Roger Murphy, Anthony Hannah, Michael Lim-Joon, Tony Chan, Geoffrey Chong, Gerd Ritter, Eric W. Hoffman, Antony W. Burgess, Lloyd J. Old, Specific Targeting, Biodistribution, and Lack of Immunogenicity of Chimeric Anti-GD3 Monoclonal Antibody KM871 in Patients With Metastatic Melanoma: Results of a Phase I Trial Journal of Clinical Oncology. ,vol. 19, pp. 3976- 3987 ,(2001) , 10.1200/JCO.2001.19.19.3976
Paul G Richardson, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Nikhil Munshi, Kenneth C Anderson, Bortezomib in the front-line treatment of multiple myeloma. Expert Review of Anticancer Therapy. ,vol. 8, pp. 1053- 1072 ,(2008) , 10.1586/14737140.8.7.1053
Phuong Dinh, Evandro de Azambuja, Fatima Cardoso, Martine J Piccart-Gebhart, Facts and controversies in the use of trastuzumab in the adjuvant setting Nature Reviews Clinical Oncology. ,vol. 5, pp. 645- 654 ,(2008) , 10.1038/NCPONC1219
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857